1/99
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Benefits of pegylated liposomal doxorubicin
protects liposomes from detection by phagocytes.
enhanced stability
increased circulation time
prevents opsionisation
how does pegylation prevent opsionisation
steric hinderance.
Peg chains create a steric barrier which prevents liposomes being coated with opsionins
what is opsionisation
the process by which pathogens are marked for destruction by the immune system through the binding of opsonins.
What is passive targeting
EPR mediated drug accumulation
what is the EPR effect
Preferential accumulation of nanoparticles in tumour tissue because of their leaky vasculature and insufficient lymphatic drainage.
things to consider when prescribing amongst various groups of people
communication
language barriers
education level
financial status if necessary
patient preference
examples of social prescribing
support groups
physical activity services
Role of cholesterol in liposomal formulation
integrates into liposomal membrane. Improves encapsulation, stability and rigidity
role of sucrose in liposomal formulation
prevents aggregation
role of ammonium sulfate in liposomal formulation
for active loading of drug into liposomes increases drug entrapment efficiency.
role of water for injections in liposomal formulation
solvent
what is the active ingredient in tumeric , what does it do, why is it unsuitable alongside some cancer treatment regimens?
active ingredient is curcumin- anti oxidant properties.
can interfere with efficacy of some cancer drugs as is a substrate for CYPa 3a4, therefore may increase the exposure of some chemotherapeutics, and increase adverse effects.
MOA- trastuzumab
binds to extracellular ligand binding domain of HER 2 receptor, blocking its activation and therefore stops downstream signalling of the PI3K and MAPK pathways.
Also affects immune cells through antibody dependent cellular cytotoxicity to destroy cancer cells.
What is the HER 2 receptor
Growth factor. Transmembrane tyrosine kinase receptor which is activated by the formation of dimers with other EGFR proteins- activates downstream signalling pathways such as MAPK, PI3K which promote cell growth and survival.
administration of trastuzumab
IV over 90mins
S/C over 2-5 mins
need adequate contraception during and 7 months after treatment.
what is trastuzumab used in
HER 2 positive breast cancer
gastric cancer
Lapatanib MOA
inhibits tyrosine kinase HER 2 receptor through phosphorylation → decreased cell proliferation and survival.
Competes with ATP to block HER 2 signalling and disrupts downstream signalling pathways.
Why is being overweight a risk factor for breast cancer
increased adipose tissue in overweight.
Aromatase converts adipose tissue to oestrogen. Increased levels of oestrogen stimulates growth of ER+ breast cancers
SERMs
Selective oestrogen receptor modulatorsthat bind to estrogen receptors, acting as agonists in some tissues and antagonists in others.
SERDs
Selective osetrogen receptor degraders. Degrade ER alpha,
IM only
more side effects than SERMs
used after SERM or AI failure.
AIs
Aromatase inhibitors.
Inhibit aromatise enzymes (which convert androgens into oestrogen) and therefore stop oestrogen synthesis.
Preferred in post menopausal women
What is high dose methotrexate used in cancer therapy
>500mg/m2
What do you need to do when administering methotrexate for cancer therapy
methotrexate MOA
inhibits dihydrofolate reductase, so DNA synthesis can’t happen.
comon toxicities w high dose methotrexate
Blood disorders
immunosuppression
hepatotoxicity
renal toxicity
What is used to prevent methotrexate toxicity, and how do they do this
Folinic acid- dampens down the inhibition of DNA synthesis by methotrexate so there is not too much of this inhibiton. Helps nor,al cells to recover and reduce side effects. Also helps to eliminate methotrexate from the body
IV fluids - promote hydration and urine output to aid methotrexate elimination and prevent renal issues.
Sodium bicarbonare - alkalanises the urine. Methotrexate is less soluble in acidic urine. Sodium bicarb is used to increase methotrex solubility in the urine and aid elimination.
Why is it important to alkalinise the urine when taking high dose methotrexate
Acidic env’ts can cause crystallisation in renal tubules which can cause blockages and further damage to the kidneys.
common interactions with methotrexate.
Some antibiotics
eg penicillins- they are weak acids and also renally excreted, so can slow methotrexate metabolism as too acidic.
ciprofloxacin- displaces methotrexate from plasma proteins.
Theophylline
epilepsy medications
PPIs
Diuretics
NSAIDs (bc reduce renal blood flow)
some HTN meds
Alcohol
other immunosuppressants
methotrexate and aciclovir
interaction- increased risk of nephrotoxicity
alternative to PPI when giving high dose methotrexate
H2 receptor antagonist eg famotidine
MOA rituximab
Monoclonal antibody that targets CD20 on B lymphocytes. This leads to the depletion of B cells, by acting on CD20, promotes cell lysis.
what is rituxumab used in
types of lymphomas, leukemia , other cancers and autoimmune diseases.
does rituximab penetrate the CNS
Not under normal conditions.
What is glucoparidase, when is it used.
Methotrexate reversal agent - rapidly hydrolyses methotrexate into inactive non cytotoxic metabolites which arent metabolised by the kidney.
Used on AKI or methotrexate induced renal dysfunction.
Very high cost.
Why is there an interaction between azole antifungals and vincristine? What antifungal can you give instead?
Azole antifungals inhibit CYP3a4 , which metabolises vincristine. Therefore, they inhibit the metabolism of vincristine, and increase exposure, which leads to enhanced toxicity. (myelosuppression, neurotoxicity, inc risk of seizures)
alternative antifungal - amphotericin B.
Safeguards for intrathecal administration
clear labelling
separate preparation and storage areas
Administered only by trained professionals
CHECK- correct medicine, dose , patient , route- these checks recorded on intrathecal drug chart
collect from pharmacy ONLY when needed for administration
intrathecal register.
What is meant by a ‘Never event’
serious preventable incidents that should not occur if proper safety procedures are followed.
Unsafe and avoidable in healthcare settings
examples of never events
administration of intrathecal vincristine
overdose of insulin - misunderstood abbreviations / incorrect device
methotrexate overdose (prescribed as weekly dose).
What is TMPT? What does it do?
enzyme involved in metabolism of thiopurine drugs eg 6MP.
TPMT methylates 6MP into an inactive form- 6 methylmercaptopurine = less toxic and less active.
Why do you get variation in the activity of TPMT among different individuals
genetic polymorphism
Metabolism of 6MP
TPMT - methylates 6mp → 6 methylmercaptopurine = less toxic and less active.
HPRT- converts 6-MP into active metabolite= 6-TGN = gives drugs cytotoxic effects.
xanthine oxidase and other enzymes- inactivate 6mp further into other metabolites which are excreted.
consequences of low and intermediate TMPT activity.
Low= slow metabolism, higher levels of active metabolite 6TGN = increased risk of toxicity such as bone marrow suppression.
intermediate= moderate response , may need dose adjustments to avoid side effects.
What is meant by a heterozygous variant
has one normal allele and one mutated copy
Basic MOAs - immunotherapy, chemotherapy and targeted therapy
immunotherapy = modifies immune system to fight cancer
chemo- kills rapidly dividing cells
taergeted- targets specific molecules or pathways in cancer.
organs affected by immunotherapy
immune system, skin, lungs, gut , liver, endocrine
organs affected by chemotherapy
Bone marrow, GIT, hair folicles, liver
organs affected by targeted therapy
skin, liver, heart, blood vessels
Management of QT prolongation in cancer treatment
monitoring electrolytes
drug interactions
review choice of cancer therapy.
What is the BCR-ABL fusion gene (philadelphia chromosome)?
arises from reciprocal translocation between chromosomes 9 and 22. encodes an active tyrosine kinase that continually sends growth and survival signals to the cell.
BCR-ABL fusion gene in CML
disrupts 1st exon of ABL leading to sustained activation of tyrosine kinase and resistance to deactivating mechanisms. leads to uncontrolled cell growth and proliferation.
imatinib MOA
Tyrosine kinase inhibitor specifically targeting the BCR-ABL protein by competitively binding to the ATP binding site, blocking the ATP binding needed for kinase activity. This inhibits activation of PI3K, JAK/STAT and RAS/MAPK pathways to decrease proliferation, induce apoptosis, cause cell cycle arrest and slow disease progression.
Adverse effects of imatinib
myelosuppression
rashes/dry skin
GI
Oedema - report significant weight gain, monitor for swelling in ankles, face.
musculoskeletal pain
fatigue
Why can paracetamol sometimes cause issues in cancer treatment
Can mask fever and temperature- may need additional monitoring.
Lab diagnostics of TLS
uric acid inc
potassium inc
phosphorous inc
calcium dec
Levels 25% increase from baseline
monitoring for TLS
uric acid
creatinine
renal function
urine output and pH
electrolytes
calcium
phosphate
ECG
seizures
Allopurinol in the treatment of TLS
Xanthine oxidase inhibitor- stops body from making uric acid.
consequence of high uric acid
renal failure
rasburicase in treatment of TLS.
breaks down uric acid by catalysing the enzymatic oxidation of uric acid to an inactive and soluble metabolite, making it easier for the kidneys to excrete.
victim drugs of allopurinol and what this means
mercaptopurine
azathioprine
theophylline
are drugs that are metabolized by xanthine oxidase, thus their effectiveness may be increased or decreased when taken with allopurinol, requiring dosage adjustments.
management of TLS
hydration -IV fluids, increase fluid intake
consider diuretic eg furosemide if urine output is not adequate
Initiate rasburicase
monitor electrolytes
do not give potassium fluids
When is rasburicase contraindicated? what to do instead in established TLS
G6PD deficiency
gove allopurinol instead.
pre screening requirements before starting treatment with 6mp
TPMT levels , may affect dosing.
monitoring with treatment of 6mp
FBC weekly until stable dose, then every 2-4wks.
LFTs
renal function
tpmt
monitor for signs of infection
GI sx
Monitor 2,4,8,12 weekly then once stable every year.
What does it mean if someone has a high level of 6TGN while on treatment with 6MP?
indicates increasef efficacy but also increased toxicity.
dose reduction needed if too toxic
what genetic factors may contribute to high levels of 6TGN in patient undergoing treatment with 6mp?
Heterozygous mutant of TMPT- slower metabolism of 6MP leads to higher levels of 6-TGN. (tmpt normally inactivates 6mp, preventing int from conversion into cytotoxic metabolites such as tgn)
what can happen with too much TGN
bone marrow toxicity
blood disorders
What are non-synonymous mutations
alters the amino acid sequence of a protein
What are synonymous mutations?
Occur in DNA sequence, but do not alter the AA sequence because the changes in the sequence does not change the codon that specifies the amino acid
AKA silent mutation.
Nonsense mutation
change in DNA that causes a protein to terminate/ end its translation earlier than expected
= stop mutation
exon
a segment of DNA or RNA that codes for a protein. Exons are typically spliced together during the processing of the precursor mRNA.
intron
Non coding section within a gene that is removed during RNA splicing before translation to proteins.
intragenic single nucleotide polymorphism
genetic variation where a single nucleotide base changes within a gene that may or may not affect protein function.
can lead to expression of genes that are silent.
D538G mutation - why does it lead to resistance to endocrine therapy?
mutation in the oestrogen receptor alpha gene.
causes conformational change to an active shape even w/o oestrogen.
when endocrine therapies are used, receptor continues to stimulate cell growth.
Why are tubulin pathways potential targets for cancer drug design
they are often overexpressed in various cancers. They are involved in several hallmarks of cancer and contribute to uncontrolled proliferation, inhibiting apoptosis, and immune evasion
their contribution to the progression of cancer makes them suitable targets for treatment.
the two types of mechanisms of resistance to immunotherapy
intrinsic and extrinisic mechanisms of resistance
Intrinsic- cancer cells alter processes relevant to immune recognition, signalling, expressiona dn DNA damage.
Extrinsic- external to tumour cells through immunological and non immunological interactions
Mechanisms of resistance to immunotherapy
impaired MHC presentation- can cause resistance to t cell mediated cytotoxicity
Poor DNA repair
epigenetic modifiers → changes to antigen processing , antigen presentation, immune evasion
Altered signalling pathways to impair anti tumour response
Persistent IFN- gamma can lead to therapy resistance
TREGS- regulatory Tcells in tumour micoenvironments - suppress effector T cells and APC, maintain immune status.
Tumour associated macrophages
Antigen masking and presentation -present inappropriate antigens for therapy.
contribution of tubulin genes and pathways involved in the immune escape of cancer cells
tubulin interacts with actin - regulates cell shape, migration and invasion, so changes to tubulin could enhance migration and aid immune escape and thus metastasis
Who can prescribe cycle one of chemotherapy?
Consultant or appropriatelt credentialed clinician ONLY
Others can only prescribe chemo that has already been initiated.
vegan vitamin d supplement option
ergocalciferol
physiological changes associated with low testosterone
weight gain
night sweats
sleep problems
bone loss
fatigue
psychological changes assoc w low testosterone
Mood changes
depression
anxiety
difficulty concentrating
low self esteem
What can help hot flushes caused by low testosterone and how does it do this
sage. mimics oestrogen in the body.
side effects of goseralin treatment
myalgia- muscle and joint pain
myosiris- inflammation of muscle
fatighe
neuropathy that could impact muscle strength
increased risk of osteoporosis.
MOA - docetaxel
Disrupts microtubules in cells so they cannot grow and divide properly, leading to death of these cancer cells.
role of dexamethasone / steroids in cancer therapy
reduce inflammation
prevent fluid retention
reduce nausea
role of filgrastim in cancer therapy
boosts WBCs - encourages bone marrow to produce more WBCs.
protect from infection and help immune recovery from chemo.
role of metoclopramide in cancer therapy
anti emetic
speeds up digestion to empty stomach more quick;y
acts on brains nausea control centre- crosses BBB - careful parkinsons , schizo.
immediate management of neutropenic sepsis
blood cultures
IV Abx
Tazocin 4.5g QDS
Gentamicin IV - DO NOT USE NEPHROTIC ABX LIKE THIS IF PT ON NEPHROTOXIC CHEMO.
high flow oxygen if sats below 94
IV fluids
check serum lactate- assess tissue hypoperfusion/ early septic shock
monitor urine outpit
dailt FBC, U&E, LFT, renal function
Self monitoring of thrombocytopaenia
unusual bruising, bleeding
avoid injury
Management of chemo induced thrombocytopaenia
platelet transfusion
growth factors
Changes in chemotherapy regimen
Key steps in metastatic spinal cord compression pathway
Diagnosis - imaging
Emergency care management - steroids, pain
Surgerym radio, or systemic therapy
Rehab and supportive care
some of the key medicines used in metastatic spinal cord compression management
corticosteroifs
pain- opioids, NSAIDSm neuropathic pain agents eg gabapentin for nerve pain
bone strengthening - bisphosphonares, denosumab
PPIs, laxatives etc to manage symptoms.
risk factors for frailty
age
lower BMI
Low excercise
polypharmacy
mental health issues- ie depression
cognitive impairment - dementia etc
poor nutrition
chronic disease
social isolation/ loneliness
Alternative therapies to manage pain/ anxiety/ depression
st johns wort
psilocybin
cbd oil
accupuncture
massages
taking therapy
therapy animals
etc
Dabrafenib MOA
ATP competitive inhibitor of mutant BRAF kinases which inhibits its kinase activity, therefore dec downstream MEK and ERK phosphorylation → inducing cell cycle arrest and apoptosis.
trametinib MOA
inhibitor of MEK1 and MEK 2. binds outside of ATP binding pocket - locks it into inactive conformation → prevents ERK phosphorylation.
Reduces proliferation , induces cell cycle arrest and triggers apoptotic pathways.
why are dabrafenib and trametinib good to use in combination therapy
Together they provide more complete pathway inhibition
They block two points in the MAPK pathway (BRAF and MEK), improving efficacy and reducing resistance compared to monotherapy.
side effect profile of trametinib
skin reactions - regular monitoring - prevent secondary infection if necessary.
GI - diarrhoea, ab pain, nausea
fatiguem peripheral oedema , fever
CV- reduced left vent ej fraction - baseline echocardiogram, then every 4-12wks
HTN- regular monitoring
Occular side effects- retinopathy , blurred vision - urgent referral if sx develop
pulmonary - pneumonitis - rare - look out for new cough/ breathlessness - imaging / pulmonary referral if applicable
canabis oil and chemotherapeutics
may mask sx/ side effects of medication
no clinical evidence for efficacy
can interfere with other chemotherapeutics